LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
Online: Watsons: | Complex White
Roubelakis MG, Trohatou O, Anagnou NP
Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder
This could be beneficial in the treatment of inflammatory bowel disease and other GI conditions
Access this article References Li X, Xu PH, Lu Q, et al